CHTH CNL Healthcare Properties Inc (PK)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒       Filed by a party other than the Registrant ☐

Check the appropriate box:

CNL HEALTHCARE PROPERTIES, INC.

(Name of Registrant as Specified in its Charter)

Not applicable.

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

FA Email

RE: CNL Healthcare Properties Annual Shareholder Meeting

Date: Oct. XX, 2024

FOR BROKER-DEALER AND RIA USE ONLY. Not for general use with the public.

Dear {{lead.Nickname:default=Financial Professional}}:

Several weeks ago, we notified you and shareholders of CNL Healthcare Properties about the company’s annual meeting on Nov. 20, 2024. The company has engaged Broadridge Investor Communication Solutions (Broadridge) to assist in soliciting shareholders’ proxies. Shareholders are being asked to vote to reelect the five directors and to ratify the independent auditor.

We are providing the information below to assist should your clients have questions.

How can a shareholder submit their vote?

Shareholders can vote by using the control number on the proxy card mailed to them or in the email, if they chose edelivery, from Broadridge.

How can a shareholder vote if they don’t have their control number?

What if my shareholder has questions?

Additional Information and Where to Find It

In connection with the matters described in this communication, the company has filed relevant materials with the Securities and Exchange Commission (the SEC), including a definitive proxy statement on Schedule 14A. The company has mailed the definitive proxy statement and a proxy card to each shareholder entitled to vote at the shareholder meeting relating to such matters. SHAREHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THESE MATERIALS WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE MATTERS DESCRIBED IN THIS COMMUNICATION. The definitive proxy statement and other relevant materials, and any other documents filed by the company with the SEC, may be obtained free of charge at the SEC’s website (www.sec.gov), or by writing to the company at 450 S. Orange Avenue, Orlando, Florida 32801 (telephone number 866-650-0650).

FOR BROKER-DEALER AND RIA USE ONLY. Not for general use with the public.

See SEC filings for complete details.

© 2024 CNL Healthcare Corp. All Rights Reserved. CNL® and the Squares Within Squares design trademarks are used under license from CNL Intellectual Properties, LLC.

CHP-1024-3973516-BD